<DOC>
	<DOCNO>NCT01607684</DOCNO>
	<brief_summary>The purpose study determine whether Magnetic Marker Monitoring appropriate opportunity diagnose quantify suspicious gastroparesis subject diabetic polyneuropathy .</brief_summary>
	<brief_title>Pilot Study Evaluate Magnetic Marker Imaging Diabetic Polyneuropathy Gastroparesis</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Gastroparesis</mesh_term>
	<mesh_term>Polyneuropathies</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<criteria>age &gt; 50 year write informed consent Diabetes mellitus ( Diabetes mellitus group ) Symptoms diabetic gastroparesis respect nausea , postprandial fullness , abdominal pain , nausea , vomit , abdominal bloating , early satiety , erratic blood glucose level weight loss evaluate standardized questionnaire ( Diabetes mellitus group ) actually measure HbA1c ( Diabetes mellitus group ) Subject pregnant breast feeding . Subject unwilling unable comply study requirement . Any investigational agent participation another clinical trial within 28 day prior randomization Any kind disorder compromise ability subject give write informed consent and/or comply study procedure . History medical condition may increase risk associate study participation may interfere interpretation study result . Known allergy investigational product , excipients Active inflammatory bowel disease , serious gastric ulceration bowel disease like e.g . coeliac disease Implanted cardiac cardioverterdefibrillator cardiac pacemaker Stenosis stricture gastrointestinal tract surgery region except cholecystectomy appendectomy Longterm medication drug , influence gastrointestinal motility ( opiate , opioids , erythromycin , metoclopramide , laxatives ) &lt; 3 day randomisation magnetic marker monitoring</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>